Types of Genetic Tests: Health, Ancestry, Paternity and Carrier Status
You have decided to take a genetic test. You open a search — and see dozens of offers. One service promises to tell you about health, another to explore ancestry, a third to confirm kinship, a fourth to assess the risk of passing hereditary conditions to a child. All of them are called genetic tests and work with DNA. But they answer different questions.
The type of sample does not determine the type of test. The purpose of the analysis does: which genetic variants are examined, what data they are compared with, and how the result is interpreted. This is why the main mistake in choosing is to buy a high-quality test that answers a different question from the one you care about.
For an explanation of how DNA analysis works, see the article DNA test and blood test: what's the difference?
The Four Questions That the Choice of Test Begins With
Each type of genetic test is built around a separate question that requires its own data, reference databases and rules of interpretation.
Which genetic features may be relevant to my health? This question is answered by a genetic health test: it examines variants associated with predispositions, metabolism and the body’s reactions.
Where does my lineage come from? This question is addressed by a DNA ancestry test, which compares your DNA with reference population panels and user databases.
Are these two people biologically related? Here a paternity or biological-relationship test does the work: it checks one specific hypothesis about two known participants.
Am I a carrier of a hereditary condition that could be passed to a child? This is the domain of carrier screening, which looks for variants capable of causing a hereditary condition in the next generation.
Four questions — four different methods. Below we look at why they are not interchangeable, even if they use one sample or partly the same genetic data.
What Determines the Type of Genetic Test
Between the sample and the report lies a chain of decisions, and it is this chain that creates the category of the test.
First, the laboratory chooses which regions of the genome to examine: a single gene, a set of SNPs, a gene panel, the exome or the whole genome. Then it decides what to compare the data obtained with: with catalogues of clinically significant variants, with reference population panels, or with the DNA of another specific person. And finally it sets the rules of interpretation: what counts as a finding, how to calculate probability, which conclusion may end up in the report.
Saliva, blood or a buccal swab are a source of DNA. They affect the procedure for obtaining the material and its quality, but on their own they do not determine the question of the test. For legally significant procedures, another level of requirements is added, and it concerns not laboratory chemistry but control over the sample itself.
The MedlinePlus resource of the U.S. National Library of Medicine lists among the main categories of consumer genetic tests the assessment of health risks, ancestry, kinship, lifestyle directions and carrier status. The same resource states the limitation plainly: there is no single genetic test that detects all genetic conditions (MedlinePlus Genetics, Types of DTC Genetic Tests, 2026).
So the tests differ at the level of design. The following sections show how that design limits each of them.
Why a Health Test Will Say Nothing About Your Ancestry
A health test is tuned to the “variant — biological effect” link. It selects those regions of DNA for which studies exist that connect them with metabolism, the cardiovascular system, the absorption of vitamins, the response to exertion, or a predisposition to certain conditions. It compares your variants with clinical and population data on the effect.
Reconstructing ancestry requires markers, reference population panels and algorithms specifically chosen to assess genetic similarity. A report on genetic health features usually does not perform such an analysis, even if some of the SNPs used overlap. The difference lies not only in the set of data but in what they are compared with and by which rules.
The depth of such a test varies: from individual monogenic findings to polygenic estimates and pharmacogenetic variants, and the level of evidence for these categories is not the same. An estimate of relative genetic risk shows a shift in probability relative to a reference population, not an absolute risk of falling ill (MedlinePlus Genetics, Pros and Cons of DTC Genetic Testing, 2026).
For a detailed breakdown of the categories of indicators in the report, see the article “What a genetic health test shows” (№81).
Why an Ancestry Test Does Not Assess Diabetes Risk
A mirror situation. An ancestry test looks for the markers that best distinguish geographic populations and compares them with a reference database. Its result is an estimate of similarity: how much your fragments of DNA resemble fragments typical of a particular region or lineage. Y-chromosome analysis traces the paternal line in people with a Y chromosome, mitochondrial DNA analysis traces the maternal line.
Such a conclusion is statistical in nature and depends on the composition of the database. An update to the reference panel can change the percentages in a report that has already been issued, and this is not a laboratory error but a property of the method (MedlinePlus Genetics, Genetic Ancestry Testing, 2026).
An estimate of similarity to a particular population cannot be directly turned into an individual probability of diseases. That requires specific variants, their weighting coefficients, a validated model and clinical context. Ancestry describes genetic history, but on its own it is not an assessment of individual risk.
Why a Genealogical Match with a Relative Is Not Proof of Paternity
A genealogical database can find a person whose genetic closeness corresponds to the level of the closest relatives. A formal paternity test differs from such a search not in sensitivity but in the construction of the question.
A genealogical database works in search mode: it compares you with everyone who has taken the test and ranks the matches found. A paternity test works in verification mode: there are two known participants and one hypothesis that the statistics must support or rule out. The laboratory compares their markers and calculates the probability of this specific relationship.
The difference that decides everything in a legal context lies outside the analytics. A home informational test does not confirm whose DNA exactly ended up in the tube. The standards of the professional association AABB for biological-relationship testing govern the work of laboratories that establish paternity and other family ties, and in particular provide for a separate designation of cases without a confirmed chain of custody of samples (AABB, Standards for Relationship Testing Laboratories, 17th ed.).
Why Carrier Screening Is Needed by People Without Any Symptoms
Carrier status for genetic diseases is arranged in such a way that it can rarely be noticed from how a person feels. For autosomal recessive conditions, a single pathogenic variant is not enough for the typical manifestations of the disease to develop. So a person may have no symptoms and learn about carrier status only after testing.
Carrier status itself is determined individually, but the risk for a future child is assessed taking into account the results of both biological parents. If both carry pathogenic variants linked to the same autosomal recessive condition, an increased risk of passing that condition to the child arises. How a person feels and the absence of symptoms do not make it possible to determine carrier status or to assess reproductive risk.
The American College of Medical Genetics and Genomics (ACMG) regards informed reproductive decisions as an established criterion of the clinical value of population carrier screening and recommends counselling before and after testing. A negative result reduces but usually does not eliminate the residual risk, since panels and methods have limits of coverage (Gregg et al., Genet Med, 2021).
At the same time, the word “carrier” does not always mean a complete absence of medical context for the person themselves: it all depends on the specific gene and variant.
What Happens When a Test Is Chosen for a Different Question
A category error rarely looks like an error. A person receives a technically correct report, produced by a good laboratory, and has no reason to distrust it. The problem emerges later, when they try to make a decision on the basis of that report that it was not intended for.
Two services may use the same microarray and analyse some of the same SNPs but have different goals, quality control, reference databases and reporting criteria. The raw file from a genealogical test can sometimes be technically uploaded into a third-party health-interpretation service, but this does not change the nature of the raw data: coverage, accuracy and the validity of the interpretation have to be assessed separately.
The consequence of such a mistake is lost time and a false sense that the needed answer has already been obtained. In reality the decision remains unmade: a genetic health-features test does not perform the function of carrier screening before pregnancy, and a genealogical match does not go through the identification procedure required by a court. The name “DNA test” describes the material of the study, but does not guarantee suitability for a specific task.
Which Question to Start Your Choice With
A clear formulation of the goal helps you avoid wasting time on a test that will answer a different question.
I want to understand my genetic health features. Assess the list of directions, the sources, the comparison populations and the format of the report.
I want to explore my family ancestry. You need an ancestry test with a reference database relevant to your region.
I want to confirm a specific biological relationship. You need a biological-relationship test, and for official procedures an accredited laboratory and controlled sample collection.
I am planning a pregnancy. You need carrier screening with medical interpretation and testing of your partner where indicated.
If the goal is medical, discuss it with a doctor or a genetic counsellor before testing.
Which Question Apixmed Prism Answers
Of the four questions described in the article, Apixmed Prism answers the first: which genetic features may be relevant to health and lifestyle. The platform assesses indicators across directions linked to metabolism, the cardiovascular system, sleep and recovery, nutrition, immunity and physical activity. The user also gains access to the raw data of the genetic testing, so new indicators can be analysed without collecting a sample again.
The scope within the category is chosen to match the depth of the task. The themed Prisma DNA tests analyse indicators for a single area of health. The Wellness genetic panel covers about 100 indicators across 5 directions. The Ultima genetic panel examines 555+ indicators across 100 categories and presents them in 25 structured reports, giving a detailed picture of the genetic context across all areas of health at once.
Apixmed Prism does not reconstruct ancestry, does not establish paternity and does not replace specialised carrier screening before pregnancy.
The Difference That Determines the Value
One DNA sample can be used for different tests, but the value of the result is determined by the question the method was created for. It sets which variants will enter the analysis, what they will be compared with, and what can become a conclusion at all. Because of this, a report on genetic health features does not reconstruct a family tree, regional percentages do not turn into individual risk, a genealogical match does not go through a legal procedure, and reproductive risk based on carrier screening is assessed taking into account the data of both biological parents. A correctly formulated question makes everything that follows useful: both the depth of the analysis and the quality of the interpretation.
View the directions of Apixmed Prism genetic tests and panels
Frequently Asked Questions
Do all DNA tests show the same thing?
They belong to different categories. All of them analyse genetic material, but tests for health, ancestry, paternity and carrier status differ in their question, method and use of the result.
Will an ancestry test show health risks?
No, unless it is a separate module. An ancestry test matches data against population panels, not against clinical risk models. A health-assessment module within such a service is assessed as a standalone product.
Can paternity be confirmed with an ancestry test?
No. A genealogical service will show a close match, but a legally significant conclusion requires verification of the participants and control of the samples.
Why does a healthy person need a carrier test?
Carrier status often has no manifestations. A single pathogenic variant is in most cases not enough for typical symptoms, so how a person feels tells nothing here. The result matters when planning a pregnancy, taking into account the data of both biological parents.
Can a genetic health test make a diagnosis?
No. It reveals an indicator for discussion with a doctor. A diagnosis is based on symptoms, medical history, examination and laboratory data.
Which question does Apixmed Prism answer?
Which genetic features may be relevant to health and lifestyle. The platform works in the category of tests for health and lifestyle. It does not determine ancestry, does not establish paternity and is not carrier screening.
The results of a genetic test are not a diagnosis and not a substitute for a doctor’s consultation. An Apixmed Prism report provides genetic context that complements the findings of examinations and helps you make decisions together with your doctor.
Sources
1. MedlinePlus Genetics. (2026). What kinds of direct-to-consumer genetic tests are available? National Library of Medicine. https://medlineplus.gov/genetics/understanding/dtcgenetictesting/dtctesttypes/
2. MedlinePlus Genetics. (2026). What is genetic ancestry testing? National Library of Medicine. https://medlineplus.gov/genetics/understanding/dtcgenetictesting/ancestrytesting/
3. MedlinePlus Genetics. (2026). What are the pros and cons of direct-to-consumer genetic testing? National Library of Medicine. https://medlineplus.gov/genetics/understanding/dtcgenetictesting/dtcrisksbenefits/
4. Centers for Disease Control and Prevention. (2024). Genetic testing. CDC Genomics and Your Health. https://www.cdc.gov/genomics-and-health/counseling-testing/genetic-testing.html
5. AABB. Standards for relationship testing laboratories (17th ed.). Association for the Advancement of Blood & Biotherapies. https://www.aabb.org/standards-accreditation/standards/relationship-testing-laboratories
6. Gregg, A. R., Aarabi, M., Klugman, S., Leach, N. T., Bashford, M. T., Goldwaser, T., Chen, E., Sparks, T. N., Reddi, H. V., Rajkovic, A., & Dungan, J. S. (2021). Screening for autosomal recessive and X-linked conditions during pregnancy and preconception: A practice resource of the American College of Medical Genetics and Genomics (ACMG). Genetics in Medicine, 23(10), 1793–1806. https://doi.org/10.1038/s41436-021-01203-z
7. Gregg, A. R., Aarabi, M., Klugman, S. et al. (2021). Correction to: Screening for autosomal recessive and X-linked conditions during pregnancy and preconception. Genetics in Medicine, 23(10), 2015. https://doi.org/10.1038/s41436-021-01300-z
